Adaptimmune Therapeutics Plc Année d'introduction en bourse
Quel est le Année d'introduction en bourse de Adaptimmune Therapeutics Plc?
Le Année d'introduction en bourse de Adaptimmune Therapeutics Plc est 2015
Quelle est la définition de Année d'introduction en bourse?
Le premier appel public à l'épargne est un type d'offre publique dans lequel les actions d'une entreprise sont généralement vendues à des investisseurs institutionnels qui, pour leur part, vendent au grand public, pour la première fois, sur une bourse de valeurs.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
Année d'introduction en bourse des entreprises dans Health Care secteur sur NASDAQ par rapport à Adaptimmune Therapeutics Plc
Que fait Adaptimmune Therapeutics Plc?
adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.
Entreprises avec année d'introduction en bourse similaire à Adaptimmune Therapeutics Plc
- Global Brands a Année d'introduction en bourse de 2014
- Antibe Therapeutics a Année d'introduction en bourse de 2014
- ArcelorMittal 5.50% Mandatorily a Année d'introduction en bourse de 2014
- The Toronto-Dominion Bank PFD SER 5 a Année d'introduction en bourse de 2014
- WisdomTree EURO STOXX Banks 3x Daily Leveraged a Année d'introduction en bourse de 2014
- Horizons Us Lrg Cap Eqty Cvrd C a Année d'introduction en bourse de 2014
- Adaptimmune Therapeutics Plc a Année d'introduction en bourse de 2015
- Larsen & Toubro Infotech a Année d'introduction en bourse de 2016
- Escape Hunt plc a Année d'introduction en bourse de 2016
- SiteOne Landscape Supply Inc a Année d'introduction en bourse de 2016
- Lloyds Steels Industries a Année d'introduction en bourse de 2016
- Liberty Media a Année d'introduction en bourse de 2016
- Atlanta Braves Inc a Année d'introduction en bourse de 2016